MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of MANKIND PHARMA ?
| Year | Current Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Current Liabilities of MANKIND PHARMA Trending?
| Years | Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Current Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹95,422.8 Cr | 2.1% | 1.7% | -24.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,681.0 Cr | 2.4% | -2.5% | -7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,324.0 Cr | 3.9% | 2.6% | 3.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,466.0 Cr | 2.5% | 4.1% | 12.3% | Stock Analytics | |
| CIPLA | ₹118,524.0 Cr | 1.3% | 0.6% | -1.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,711.0 Cr | -1.2% | -1.5% | -9.1% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 2.1% |
1.7% |
-24.4% |
| SENSEX | -0.3% |
-0.9% |
6.3% |
You may also like the below Video Courses